Key result
Among patients discharged after major orthopedic surgery, 93.8% were prescribed pharmacologic thromboprophylaxis, but 78.4% reported a duration of fewer than 35 days, indicating suboptimal adherence to clinical guidelines.
Why the study?
Little research has described adherence to American College of Chest Physicians thromboprophylaxis recommendations during recovery at home after major orthopedic surgery.
What are the patterns of thromboprophylaxis prescription, use, and education among patients discharged home after major orthopedic surgery?
Cross-Sectional (n=388)
What are the patterns of thromboprophylaxis prescription, use, and education among patients discharged home after major orthopedic surgery?
There is a significant gap between guideline recommendations and actual outpatient practice regarding the duration and type of thromboprophylaxis after major orthopedic surgery.
Answers are grounded in this paper and cite their sources.
Shortfalls in post-orthopedic thromboprophylaxis duration and adherence persist; leaves open whether targeted education closes guideline gaps.
Venous thromboembolism (VTE) is a leading cause of mortality during the perioperative period, with individuals who have undergone hip and knee arthroplasty at the highest risk for VTE. The American College of Chest Physicians recommends 35 days of postoperative thromboprophylaxis and the use of intermittent pneumatic compression (IPC) therapy for mechanical compression after major orthopedic surgery. However, little research has described adherence to these recommendations during recovery at home. The purpose of this cross-sectional descriptive study was to describe thromboprophylaxis prescription, use, and education among patients discharged home after major orthopedic surgery. We surveyed patients within 2 years of major orthopedic surgery. A total of 388 subjects completed the survey. More than three-quarters of respondents reported a thromboprophylaxis duration <35 days. Most (93.8%) respondents were prescribed a pharmacologic agent, while 55.9% were prescribed mechanical compression therapy. Of the respondents who were prescribed mechanical compression therapy, 13.4% were prescribed IPC. Adherence to mechanical compression therapy was moderate, with 63% of respondents wearing mechanical compression therapy ≥75% of the time. The results of this study suggest a need for increased duration of thromboprophylaxis and increased use of IPC in the outpatient setting. Additional research describing prescribers' perceptions of thromboprophylaxis is also needed.
No takes yet. Share an insight, caveat, or question.
Giuliano et al. (2019) conducted a cross-sectional in Major orthopedic surgery (hip or knee replacement) (n=388). Thromboprophylaxis prescription and adherence was evaluated on Thromboprophylaxis prescription, duration, and adherence. Among patients discharged after major orthopedic surgery, 93.8% were prescribed pharmacologic thromboprophylaxis, but 78.4% reported a duration of fewer than 35 days, indicating suboptimal adherence to clinical guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: